Latest & greatest articles for Gestational Diabetes Management

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on Gestational Diabetes Management or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on Gestational Diabetes Management and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for Gestational Diabetes Management

1. Fetal biometry for guiding the medical management of women with gestational diabetes mellitus for improving maternal and perinatal health. (PubMed)

Fetal biometry for guiding the medical management of women with gestational diabetes mellitus for improving maternal and perinatal health. Gestational diabetes mellitus (GDM) is a common medical condition that complicates pregnancy and causes adverse maternal and fetal outcomes. At present, most treatment strategies focus on normalisation of maternal blood glucose values with use of diet, lifestyle modification, exercise, oral anti-hyperglycaemics and insulin. This has been shown to reduce (...) the incidence of adverse outcomes, such as birth trauma and macrosomia. However, this involves intensive monitoring and treatment of all women with GDM. We propose that using medical imaging to identify pregnancies displaying signs of being affected by GDM could help to target management, allowing low-risk women to be spared excessive intervention, and facilitating better resource allocation.We wanted to address the following question: in women with gestational diabetes, does the use of fetal imaging plus

2019 Cochrane

2. Diagnosis, prevention and management of gestational diabetes mellitus (PubMed)

Diagnosis, prevention and management of gestational diabetes mellitus 29063042 2019 01 16 2095-882X 2 4 2016 Dec Chronic diseases and translational medicine Chronic Dis Transl Med Diagnosis, prevention and management of gestational diabetes mellitus. 199-203 10.1016/j.cdtm.2016.11.004 Wang Chen C Department of Obstetrics and Gynecology of Peking University First Hospital, Beijing 100034, China. Yang Hui-Xia HX Department of Obstetrics and Gynecology of Peking University First Hospital, Beijing (...) 100034, China. eng Editorial 2016 12 04 China Chronic Dis Transl Med 101679934 2095-882X Diagnosis Gestational diabetes mellitus Management Postpartum follow-up Prevention 2016 08 10 2017 10 25 6 0 2017 10 25 6 0 2017 10 25 6 1 epublish 29063042 10.1016/j.cdtm.2016.11.004 S2095-882X(16)30062-7 PMC5643832 Int J Gynaecol Obstet. 2010 Oct;111(1):37-40 20542272 Diabetes Care. 2003 Aug;26(8):2261-7 12882846 BMC Pregnancy Childbirth. 2014 Jan 22;14:41 24450389 Obstet Gynecol Clin North Am. 2007 Jun;34(2

Full Text available with Trip Pro

2016 Chronic diseases and translational medicine

3. Immediate delivery or expectant management in gestational diabetes at term: the GINEXMAL randomised controlled trial

Immediate delivery or expectant management in gestational diabetes at term: the GINEXMAL randomised controlled trial To evaluate maternal and perinatal outcomes after induction of labour versus expectant management in pregnant women with gestational diabetes at term.Multicentre open-label randomised controlled trial.Eight teaching hospitals in Italy, Slovenia, and Israel.Singleton pregnancy, diagnosed with gestational diabetes by the International Association of Diabetes and Pregnancy Study (...) diabetes, without other maternal or fetal conditions, no difference was detected in birth outcomes regardless of the approach used (i.e. active versus expectant management). Although the study was underpowered, the magnitude of the between-group difference was very small and without clinical relevance.Immediate delivery or expectant management in gestational diabetes at term?© 2016 Royal College of Obstetricians and Gynaecologists.

Full Text available with Trip Pro

2016 EvidenceUpdates

4. Flowchart: Intrapartum management for gestational diabetes mellitus requiring Insulin and/or Metformin

Flowchart: Intrapartum management for gestational diabetes mellitus requiring Insulin and/or Metformin Document Number: F15.33--2-V1-R20 Department of Health Queensland Clinical Guidelines State of Queensland (Queensland Health) 2015 http://creativecommons.org/licenses/by-nc-nd/3.0/au/deed.en Queensland Clinical Guidelines, Guidelines@health.qld.gov.au Intrapartum management for GDM requiring Insulin and/or Metformin Metformin • Cease when labour established Insulin • Cease when labour

2015 Queensland Health

5. Randomised controlled trial: Should metformin be preferred over insulin therapy in the management of gestational diabetes (GDM)?

Randomised controlled trial: Should metformin be preferred over insulin therapy in the management of gestational diabetes (GDM)? Should metformin be preferred over insulin therapy in the management of gestational diabetes (GDM)? | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Should metformin be preferred over insulin therapy in the management of gestational diabetes (GDM)? Article Text Therapeutics Randomised controlled trial Should

2013 Evidence-Based Medicine (Requires free registration)

6. Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis (PubMed)

Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis The objective of this review was to provide pooled estimates of randomized controlled trials comparing the effects of oral hypoglycemic agents with insulin in achieving glycemic control and to study the maternal and perinatal outcomes in gestational diabetes mellitus.A protocol for the study was developed. All metaanalyses were performed using Stats Direct statistical software (Stats (...) of caesarean section (OR, 0.91; 95% CI, -0.68 to 1.22), or incidence of large-for-gestational-age babies (OR, 1.01; 95% CI, 0.61-1.68).Our study demonstrates that there are no differences in glycemic control or pregnancy outcomes when OHAs were compared with insulin.Copyright © 2010 Mosby, Inc. All rights reserved.

2010 EvidenceUpdates

7. What is known about options and approaches to intrapartum management of women with gestational diabetes mellitus (GDM)?

What is known about options and approaches to intrapartum management of women with gestational diabetes mellitus (GDM)? KTA Evidence Summary: Intrapartum Management of Patients with Gestational Diabetes Mellitus (GDM) Page 1 of 19 May 2010 May 2010 – Knowledge to Action Evidence Summary What is known about options and approaches to fetal surveillance and intrapartum management of women with gestational diabetes mellitus (GDM)? This report aims to summarize the evidence around the intrapartum (...) management of women with gestational diabetes mellitus (GDM) to help inform evidence-based guidelines and advance practice in the province of Ontario. Key Messages ? Gestational Diabetes Mellitus (GDM) can cause serious complications in the intrapartum care of pregnant women and their fetuses. The impact and treatment differs somewhat from that of Type 1 and Type 2 diabetes. ? Fetal surveillance is a key aspect of the intrapartum care of the fetus. The most prominent methods appear to be: fetal movement

2010 OHRI Knowledge to Action

8. Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis

Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis Dhulkotia JS, Ola B, Fraser R, Farrell T CRD summary This review found no significant differences between oral hypoglycaemic agents and insulin in glycaemic (...) , these agents may be used as adjunctive treatments to insulin in the management of gestational diabetes. CRD commentary The review addressed a clear question. Criteria for the inclusion of studies were defined. Appropriate electronic databases were used to identify relevant studies. There were no language restrictions. The review appeared to be restricted to published studies, so there was some risk of publication bias. Steps were taken by the reviewers to minimise errors and bias at all parts of the review

2010 DARE.

9. Active Compared With Expectant Delivery Management in Women With Gestational Diabetes: A Systematic Review (PubMed)

Active Compared With Expectant Delivery Management in Women With Gestational Diabetes: A Systematic Review We conducted a systematic review to estimate benefits and harms of the choice of timing of induction or elective cesarean delivery based on estimated fetal weight or gestational age in women with gestational diabetes mellitus (GDM).An electronic literature search was performed using MEDLINE, EMBASE, the Cumulative Index to Nursing and Allied Health Literature, and The Cochrane Central (...) Register of Controlled Trials from inception to January 2007.Two investigators independently reviewed titles and abstracts, assessed article quality, and abstracted data. Maternal outcomes included cesarean delivery and operative vaginal delivery. Neonatal outcomes included birth weight, macrosomia, large for gestational age, shoulder dystocia, birth trauma, neonatal intensive care admissions, and perinatal mortality.Five studies met our inclusion criteria: one randomized controlled trial (RCT

2009 EvidenceUpdates

10. Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes

Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes Nicholson W K, Wilson L M, Witkop C T, Baptiste-Roberts K, Bennett W L, Bolen S, Barone B B, Golden S H, Gary T L, Neale D M, Bass E B CRD summary This review assessed treatment, delivery (...) -gm OGTT test for detection of type 2 diabetes in women with gestational diabetes. Research: the authors stated that well-designed RCTs should be conducted to compare elective induction and caesarean delivery with expectant management in women with gestational diabetes. Observational studies in these areas should use consistent outcome measures and multivariate adjustment for confounders. Longitudinal studies should develop and employ standard protocols to increase follow-up rates and should

2008 DARE.

11. Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes

Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes Nicholson WK, Wilson LM, Witkop CT, Baptiste-Roberts K, Bennett WL, Bolen S, Barone BB, Golden SH, Gary TL, Neale DM, Bass EB Citation Nicholson WK, Wilson LM, Witkop CT, Baptiste-Roberts K (...) , Bennett WL, Bolen S, Barone BB, Golden SH, Gary TL, Neale DM, Bass EB. Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes. Rockville: Agency for Healthcare Research and Quality (AHRQ). Evidence Report/Technology Assessment No. 162. 2008 Authors' objectives

We focused on four questions: (1) What are the risks and benefits of an oral diabetes agent (i.e., glyburide), as compared to all types of insulin, for gestational diabetes? (2) What

2008 Health Technology Assessment (HTA) Database.

12. Screening and active management reduced perinatal complications more than routine care in gestational diabetes

Screening and active management reduced perinatal complications more than routine care in gestational diabetes Screening and active management reduced perinatal complications more than routine care in gestational diabetes | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Screening and active management reduced perinatal complications more than routine care in gestational diabetes Article Text Therapeutics Screening and active

Full Text available with Trip Pro

2006 Evidence-Based Medicine (Requires free registration)

13. Managed care does not lower costs but may result in poorer outcomes for patients with gestational diabetes

Managed care does not lower costs but may result in poorer outcomes for patients with gestational diabetes Managed care does not lower costs but may result in poorer outcomes for patients with gestational diabetes Managed care does not lower costs but may result in poorer outcomes for patients with gestational diabetes Bienstock J L, Blakemore K J, Wang E, Presser D, Misra D, Pressman E K Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion (...) on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Management of gestational diabetes; Female genital diseases and pregnancy complications. Type of intervention Primary prevention and secondary prevention. Economic study type Cost-effectiveness analysis. Study population Patients with diagnosed gestational diabetes. Setting Primary care

1997 NHS Economic Evaluation Database.